Send mail to Author

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    _____     _____     ______   _____       ___    
 /_____//  |  ___||  /  ___||  /_   _// |  __ \\    / _ \\  
 `____ `   | ||__   | // __     -| ||-  | |  \ ||  / //\ \\ 
 /___//    | ||__   | \\_\ ||   _| ||_  | |__/ || |  ___  ||
 `__ `     |_____||  \____//   /_____// |_____//  |_||  |_||
 /_//      `-----`    `---`    `-----`   -----`   `-`   `-` 
 `-`
 


Back to frontdoor view

OPUS4 Logo